Selective Gut-Related Biomarker Profiles Define Parkinson Disease Trait and State

Objective: Gut-brain-axis abnormalities are increasingly implicated in Parkinson disease (PD), but most studies examine individual biological compartments of this axis. We asked whether readily accessible stool and plasma-based biomarker profiles show broad or selective gut abnormalities in PD and whether the profiles associated with PD diagnosis (Trait) are the same as those associated with clinical severity (State). Methods: This cross-sectional study included 211 participants with PD and 204 healthy controls. Twenty-four stool and plasma biomarkers were organized into an overall profile, three parent domains (microbiome/dysbiosis, gut barrier/inflammation, systemic inflammation/immune activation), and eight more focused mechanistic profiles. Rank-based Global Statistical Tests (GSTs) compared PD Trait and State. Results: The overall profile showed no evidence of a PD vs. control difference (GST P=0.607; permutation P=0.521), whereas the domain of microbiome/dysbiosis differed (GST P=0.017; permutation P=0.013). Four of eight focused profiles differed nominally: microbial functional-groups, microbial functional-ratios, epithelial injury/bacterial translocation, and myeloid activation. Across PD clinical severity, overall-profile results differed (GST P=0.053; permutation P=0.037); both categories of microbiome/dysbiosis (GST P=0.023; permutation P=0.016) and microbial alpha-diversity (GST P=0.027; permutation P=0.031) differed. Interpretation: The analyses detected differences associated with PD Trait and State in selected gut-related profiles rather than a detectable overall PD-control difference. Microbiome-related profiles showed the most consistent domain findings across PD Trait and State, but they are sufficiently different to suggest that causation and progression of PD follow distinctly different gut processes. These findings refine the concept of the Parkinson gut and prioritize the microbiome for mechanistic and interventional studies.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-16
DOI
https://doi.org/10.64898/2026.11.12.766217
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Selective Gut-Related Biomarker Profiles Define Parkinson Disease Trait and State

Leila B. Giron, Stefan J. Green, Michelle Villanueva, Amanda Pires Bonfanti et al.
2 links
bioRxiv (Cold Spring Harbor Laboratory)
Parkinson's Disease Mechanisms and Treatments
preprint

Selective Gut-Related Biomarker Profiles Define Parkinson Disease Trait and State

Leila B. Giron, Stefan J. Green, Michelle Villanueva, Amanda Pires Bonfanti, Robin M. Voigt, Sheng Luo, Mohamed Abdel‐Mohsen, Phillip A. Engen, Christopher G. Goetz, Ali Keshavarzian, Mohammad Samsul Alam, Neha Joshi, Ankur Naqib, Maliha Shaikh
preprint en

Abstract

Objective: Gut-brain-axis abnormalities are increasingly implicated in Parkinson disease (PD), but most studies examine individual biological compartments of this axis. We asked whether readily accessible stool and plasma-based biomarker profiles show broad or selective gut abnormalities in PD and whether the profiles associated with PD diagnosis (Trait) are the same as those associated with clinical severity (State). Methods: This cross-sectional study included 211 participants with PD and 204 healthy controls. Twenty-four stool and plasma biomarkers were organized into an overall profile, three parent domains (microbiome/dysbiosis, gut barrier/inflammation, systemic inflammation/immune activation), and eight more focused mechanistic profiles. Rank-based Global Statistical Tests (GSTs) compared PD Trait and State. Results: The overall profile showed no evidence of a PD vs. control difference (GST P=0.607; permutation P=0.521), whereas the domain of microbiome/dysbiosis differed (GST P=0.017; permutation P=0.013). Four of eight focused profiles differed nominally: microbial functional-groups, microbial functional-ratios, epithelial injury/bacterial translocation, and myeloid activation. Across PD clinical severity, overall-profile results differed (GST P=0.053; permutation P=0.037); both categories of microbiome/dysbiosis (GST P=0.023; permutation P=0.016) and microbial alpha-diversity (GST P=0.027; permutation P=0.031) differed. Interpretation: The analyses detected differences associated with PD Trait and State in selected gut-related profiles rather than a detectable overall PD-control difference. Microbiome-related profiles showed the most consistent domain findings across PD Trait and State, but they are sufficiently different to suggest that causation and progression of PD follow distinctly different gut processes. These findings refine the concept of the Parkinson gut and prioritize the microbiome for mechanistic and interventional studies.

bioRxiv (Cold Spring Harbor Laboratory)
Northwestern University (US), Rush University Medical Center (US), Duke University (US)
Parkinson's Foundation, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIH Clinical Center
Good health and well-being
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon